1. Home
  2. EOLS vs DBCA Comparison

EOLS vs DBCA Comparison

Compare EOLS & DBCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Evolus Inc.

EOLS

Evolus Inc.

HOLD

Current Price

$7.61

Market Cap

500.0M

Sector

Health Care

ML Signal

HOLD

DBCA

D. Boral Acquisition I Corp. Class A Ordinary Shares

SELL

Current Price

$10.05

Market Cap

432.3M

Sector

Finance

ML Signal

SELL

Company Overview

Basic Information
Metric
EOLS
DBCA
Founded
2012
2025
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Blank Checks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
500.0M
432.3M
IPO Year
2018
2025

Fundamental Metrics

Financial Performance
Metric
EOLS
DBCA
Price
$7.61
$10.05
Analyst Decision
Buy
Analyst Count
6
0
Target Price
★ $15.00
N/A
AVG Volume (30 Days)
★ 669.0K
126.2K
Earning Date
11-04-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
★ 1.23
N/A
EPS
N/A
★ N/A
Revenue
★ $297,176,000.00
N/A
Revenue This Year
$12.44
N/A
Revenue Next Year
$17.37
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 11.61
N/A
52 Week Low
$3.86
$9.83
52 Week High
$9.31
$10.10

Technical Indicators

Market Signals
Indicator
EOLS
DBCA
Relative Strength Index (RSI) 51.57 55.46
Support Level $7.59 $9.98
Resistance Level $7.83 $10.07
Average True Range (ATR) 0.32 0.01
MACD 0.02 0.00
Stochastic Oscillator 79.57 60.00

Price Performance

Historical Comparison
EOLS
DBCA

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company offering medical aesthetic products in the cash-pay aesthetic market. The company's commercially available products represent two product categories within medical aesthetics: injectable neurotoxins and injectable hyaluronic acid (HA) gels. Its commercial products are: Jeuveau, a proprietary 900-kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe frown lines, in adults; and Evolysse, a collection of injectable HA gels that utilizes first-generation cold technology. The line includes several products, including mid face, nasolabial folds, lips, and eyes. Geographically, the company currently has operations in the United States, Canada, Europe, and Australia.

About DBCA D. Boral Acquisition I Corp. Class A Ordinary Shares

D Boral Acquisition I Corp is a blank check company. It is formed as a BVI business company and formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.

Share on Social Networks: